PCENARE Stock Latest News
Private CompaniesINNA-051 Phase 2 Study Targets Viral Respiratory Complications2d agoENARE
Private CompaniesENA Respiratory Highlights Progress of INNA-051 Nasal Spray in Phase IIa Study1M agoENARE
Private CompaniesENA Respiratory Advances Phase IIa Study of INNA-051 Nasal Antiviral2M agoENARE
Private CompaniesENA Respiratory Expands Asthma Clinical Program With Incubator Support2M agoENARE
Private CompaniesENA Respiratory Secures Funding for INNA-051 Asthma Clinical Study2M agoENARE
Private CompaniesENA Respiratory Highlights Progress of INNA-051 and Industry Engagement at IPAC-RS2M agoENAREPrivate CompaniesENA Respiratory Strengthens INNA-051 Clinical Momentum and Patent Protection5M agoENARE
Private CompaniesENA Respiratory Advances INNA-051 Phase IIa Study and Targets Partnering at BIO 20265M agoENARE
Private CompaniesENA Respiratory Highlights Patent Portfolio Strength Around INNA-051 Program5M agoENARE
Private CompaniesENA Respiratory Expands U.S. Patent Protection for TLR2 Respiratory Therapies5M agoENARE
Private CompaniesENA Respiratory Advances INNA-051 Trial And Highlights Strong Antiviral Demand Signals6M agoENAREPrivate CompaniesSurvey Data and ATS Presentation Spotlight ENA Respiratory’s Antiviral Focus6M agoENARE
Private CompaniesENA Respiratory Advances INNA-051 Phase IIa Trial for Respiratory Virus Prophylaxis6M agoENARE
Private CompaniesENA Respiratory Advances Phase IIa Trial of INNA-051 for Respiratory Virus Prevention6M agoENARE
Private CompaniesENA Respiratory – Weekly Recap6M agoENARE
Private CompaniesENA Respiratory Strengthens Board With Experienced Respiratory Dealmaker7M agoENAREPrivate CompaniesENA Respiratory Strengthens Board With Experienced Respiratory Deal-Maker7M agoENARE
Private CompaniesENA Respiratory Adds Veteran Dealmaker to Board as INNA-051 Advances in Clinic7M agoENARE



